Skip to Main Content

Paper Details

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.
J Clin Invest
252
2019
59-gene signature, AR, AR-FL, AR-V7, AR-V7 antibody, AR-V7 protein, Androgen, Androgen receptor splice variant-7, CRM064X, CRPC, Cancer, HOXB13, PC, PSA, Prostate Cancer, abiraterone acetate, androgen, androgen receptor splice variant-7, castration-resistant prostate cancer, full-length androgen receptor, mRNA, patient, prostate cancer, prostate-specific antigen
Author NameAffiliation
Adam SharpThe Institute of Cancer Research
Adam Sharp
Ilsa ColemanFred Hutchinson Cancer Research Center
Wei YuanThe Institute of Cancer Research
Colm MorrisseyUniversity of Washington
Suzanne CarreiraThe Institute of Cancer Research
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
Steven P BalkBeth Israel Deaconess Medical Center
Lawrence D TrueUniversity of Washington
Johann S de BonoThe Institute of Cancer Research
Johann S de Bono
Stephen R PlymateUniversity of Washington
Stephen R PlymateGeriatric Research Education and Clinical Center (PSVAHCS-GRECC)
  • 1 - 16

Datasets

Release 1.2